Severe digital vasospasm caused by cabergoline.
Al-Zubaidi
Amani S
AS
Department of Medicine, Division of Endocrinology, Tawam Hospital, Al Ain, Abu Dhabi, United Arab Emirates.
Afandi
Bachar
B
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077465:Cabergoline; D003251:Constriction, Pathologic / Q000139:chemically induced; D004873:Ergolines / Q000009:adverse effects*; D005260:Female; D005385:Fingers / Q000098:blood supply*; D006801:Humans; D016491:Peripheral Vascular Diseases / Q000139:chemically induced*; D010911:Pituitary Neoplasms / Q000188:drug therapy; D015175:Prolactinoma / Q000188:drug therapy
D000970:Antineoplastic Agents; D004873:Ergolines; D000077465:Cabergoline